| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024623896 |
| P356 | DOI | 10.1186/GM345 |
| P932 | PMC publication ID | 3506912 |
| P698 | PubMed publication ID | 22640877 |
| P5875 | ResearchGate publication ID | 225068686 |
| P2093 | author name string | Philippos C Patsalis | |
| Elisavet A Papageorgiou | |||
| P2860 | cites work | Accuracy of fetal gender determination by analysis of DNA in maternal plasma | Q74542315 |
| Inconsistency of fetal trophoblast cells in first trimester maternal peripheral blood prevents non-invasive fetal testing using this cell target | Q74612804 | ||
| Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma | Q77372981 | ||
| Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum | Q77543801 | ||
| The use of in vitro expanded erythroid cells in a model system for the isolation of fetal cells from maternal blood | Q77748744 | ||
| Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients | Q77804773 | ||
| A comparison of different density gradients and antibodies for enrichment of fetal erythroblasts by MACS | Q78030801 | ||
| Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction | Q78175404 | ||
| Detection of SNPs in the plasma of pregnant women and in the urine of kidney transplant recipients by mass spectrometry | Q79362857 | ||
| Noninvasive prenatal diagnostic assay for the detection of beta-thalassemia | Q79362858 | ||
| A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study | Q79756571 | ||
| What potent blood: non-invasive prenatal genetic diagnosis and the transformation of modern prenatal care | Q80425451 | ||
| Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms | Q82218765 | ||
| Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting | Q83395075 | ||
| Noninvasive prenatal diagnosis in 2020 | Q84463573 | ||
| Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 | ||
| Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 | ||
| DNA methylation profiling of human chromosomes 6, 20 and 22 | Q24607522 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs) | Q24655589 | ||
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Digital PCR | Q24685020 | ||
| The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 | ||
| The epigenomics of cancer | Q28289975 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing | Q28742844 | ||
| Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics | Q28752377 | ||
| Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells | Q29618090 | ||
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
| Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. | Q30704921 | ||
| Chip-based genotyping by mass spectrometry | Q30761976 | ||
| HLA-G positive trophoblastic cells in transcervical samples and their isolation and analysis by laser microdissection and QF-PCR. | Q30762981 | ||
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Hypermethylation of RASSF1A in human and rhesus placentas | Q33275493 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| Prenatal diagnosis of trisomy 21 through detection of trophoblasts in cervical smears | Q33578717 | ||
| Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker | Q33797671 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Detection of the placental epigenetic signature of the maspin gene in maternal plasma. | Q34078379 | ||
| Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. | Q34168875 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Invasive prenatal diagnostic techniques. | Q34501680 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| Clinical practice. Prenatal screening for aneuploidy | Q34986134 | ||
| Noninvasive prenatal diagnosis of a fetal microdeletion syndrome | Q35020502 | ||
| Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis | Q35033076 | ||
| Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. | Q35216798 | ||
| PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies | Q35249607 | ||
| Epigenomics: beyond CpG islands. | Q35778671 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time | Q36274725 | ||
| Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy | Q36406163 | ||
| Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review | Q36927303 | ||
| MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. | Q36986986 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis | Q37059519 | ||
| Recent progress in non-invasive prenatal diagnosis | Q37061299 | ||
| Post-genomics studies and their application to non-invasive prenatal diagnosis. | Q37077068 | ||
| Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies | Q37164146 | ||
| The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis | Q37306246 | ||
| Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood | Q37322448 | ||
| Detection of circulating fetal nucleic acids: a review of methods and applications | Q37426191 | ||
| Rapid prenatal diagnosis of aneuploidy from uncultured amniotic fluid cells using five-colour fluorescence in situ hybridization | Q39387276 | ||
| Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. | Q39904859 | ||
| Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. | Q39906674 | ||
| Life-span of the fetal red blood cell | Q40043189 | ||
| Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody | Q40885662 | ||
| Human aneuploidy: incidence, origin, and etiology | Q41202582 | ||
| Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling | Q43073656 | ||
| Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. | Q44079689 | ||
| Stability of endogenous and added RNA in blood specimens, serum, and plasma | Q44153103 | ||
| Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood | Q44645735 | ||
| Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss | Q46987831 | ||
| Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms | Q47423342 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| Proteomics: a novel methodology to complement prenatal diagnosis of chromosomal abnormalities and inherited human diseases | Q47578976 | ||
| Detection of aneuploidy with digital polymerase chain reaction | Q48567144 | ||
| The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. | Q50939459 | ||
| A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma. | Q51959098 | ||
| Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. | Q53094776 | ||
| Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. | Q54688617 | ||
| Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. | Q54770850 | ||
| Methods to Increase the Percentage of Free Fetal DNA Recovered From the Maternal Circulation | Q56001879 | ||
| Treatment of Maternal Blood Samples with Formaldehyde Does Not Alter the Proportion of Circulatory Fetal Nucleic Acids (DNA and mRNA) in Maternal Plasma | Q56001881 | ||
| Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome | Q56765605 | ||
| ??? | Q94720111 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients | Q57240090 | ||
| Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasmaSERPINB2mRNA: a feasibility study | Q58029246 | ||
| Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21 | Q58029321 | ||
| Noninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical Considerations | Q58029492 | ||
| Detection of Trisomy 21 by Quantitative Mass Spectrometric Analysis of Single-Nucleotide Polymorphisms | Q58029594 | ||
| Lack of Dramatic Enrichment of Fetal DNA in Maternal Plasma by Formaldehyde Treatment | Q58029623 | ||
| Optimization of nucleated red blood cell (NRBC) recovery from maternal blood collected using both layers of a double density gradient | Q61021678 | ||
| Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma | Q63315257 | ||
| Detection of Chromosome 21-encoded mRNA of Placental Origin in Maternal Plasma | Q63359242 | ||
| Allele drop-out can occur in alleles differing by a single nucleotide and is not alleviated by preamplification or minor template increments. | Q64913439 | ||
| Post-partum survival of fetal lymphocytes in the maternal blood | Q67543771 | ||
| Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry | Q67779086 | ||
| Magnetic cell sorting and the transferrin receptor as potential means of prenatal diagnosis from maternal blood | Q68139499 | ||
| Prenatal diagnosis of Down's syndrome | Q70089435 | ||
| Fetal cells in maternal blood: recovery by charge flow separation | Q71235377 | ||
| Enrichment of fetal cells from maternal blood by high gradient magnetic cell sorting (double MACS) for PCR-based genetic analysis | Q71683040 | ||
| Detection of trisomy 18 and Y-derived sequences in fetal nucleated cells obtained by transcervical flushing | Q72227303 | ||
| A morphologic study of trophoblast isolated from peripheral blood of pregnant women | Q72410788 | ||
| Simple and fast "double-MACS" sorting of fetal erythroblasts from maternal blood for PCR-based paternity analysis | Q72764163 | ||
| Prenatal DNA diagnosis of a single-gene disorder from maternal plasma | Q73074402 | ||
| Presence of fetal RNA in maternal plasma | Q73162878 | ||
| Apoptosis in fetal nucleated erythrocytes circulating in maternal blood | Q73290722 | ||
| Prenatal detection of fetal hemoglobin E gene from maternal plasma | Q73398751 | ||
| Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum | Q74250288 | ||
| Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques | Q74502860 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 46 | |
| P577 | publication date | 2012-05-28 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | Non-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications | |
| P478 | volume | 4 |
| Q28550894 | A Non-Invasive Droplet Digital PCR (ddPCR) Assay to Detect Paternal CFTR Mutations in the Cell-Free Fetal DNA (cffDNA) of Three Pregnancies at Risk of Cystic Fibrosis via Compound Heterozygosity |
| Q35738581 | Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing |
| Q88990659 | Current approaches on non-invasive prenatal diagnosis: Prenatal genomics, transcriptomics, personalized fetal diagnosis |
| Q33702225 | Detection of fetal epigenetic biomarkers through genome-wide DNA methylation study for non-invasive prenatal diagnosis |
| Q36384651 | Effects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma |
| Q24186694 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women |
| Q47618331 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. |
| Q48276430 | Haplotype-based Noninvasive Prenatal Diagnosis of Hyperphenylalaninemia through Targeted Sequencing of Maternal Plasma. |
| Q41475376 | Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma. |
| Q38181003 | Lab-on-a-chip technology: impacting non-invasive prenatal diagnostics (NIPD) through miniaturisation |
| Q36335133 | Non-Invasive Screening Tools for Down's Syndrome: A Review |
| Q38770436 | Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis. |
| Q26783426 | Noninvasive prenatal diagnosis |
| Q92839651 | PLAC4 mRNA SNP in non-invasive prenatal testing of Down syndrome |
| Q92619561 | Principles of digital PCR and its applications in current obstetrical and gynecological diseases |
| Q33891689 | The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis |
Search more.